StockCall Insight into Eli Lilly, Bristol-Myers Squibb, Astex Pharmaceuticals and Raptor Pharmaceuticals

StockCall Insight into Eli Lilly, Bristol-Myers Squibb, Astex Pharmaceuticals
                          and Raptor Pharmaceuticals

Drug Company Stocks Stay Strong

PR Newswire

LONDON, February 28, 2013

LONDON, February 28, 2013 /PRNewswire/ --

Markets responded well to Fed chief Ben Bernanke's remarks about the stimulus
policy. On the other hand, there are some worries about the ongoing
Sequestration debate as well. However, broader indices remained in the green
and The Dow Jones closed 1.26% higher at 14,075.37, the S&P 500 closed 1.27%
higher at 1,515.99, and the NASDAQ closed 1.04% higher at 3,162.26. Our
research team took a look at major drug makers stocks including companies like
Eli Lilly & Co. (NYSE: LLY), Bristol Myers Squibb Co. (NYSE: BMY), Astex
Pharmaceuticals Inc. (NASDAQ: ASTX) and Raptor Pharmaceutical Corp. (NASDAQ:
RPTP). StockCall has issued technical analysis and charting reports on LLY,
BMY, ASTX and RPTP. Download these free reports now at

Eli Lilly & Co. is currently in a bullish mode as the stock created a new
52-week high price in its latest trading session. The stock closed the session
at $54.80, up 0.68 percent. Eli Lilly traded in the range of $54.26 and $54.99
during the session. Its first support level is at $53.83 and upon breaching
this level, the stock may go down to $52.46 level. On the upside, Eli Lilly &
Co.'s stock may touch $57.44 level. The stock has traded in the range of
$38.56 and $54.99 in the past 52 weeks and it grew by 40 percent during the
same time period. On a Year-to-Date basis, the stock is up 11.11 percent.
Download the free research on LLY today by registering at

Bristol Myers Squibb Co.'s shares also touched a new 52-week high in its
latest trading session, ending the day 1.95 percent higher at $37.10. The
stock fell to an intra-day low of $36.31, while its intra-day high stood at
$37.22. With the upward movement, the stock grew more than 13 percent this
year, compared to a gain of 6.3 percent for the S&P 500. The stock has strong
support at around $37.03, as it shows a bullish trend. The stock is trading
below than its 20-day and 50-day moving averages. Sign up and have access to
our free report on BMY at

Astex Pharmaceuticals traded in the range of $3.08 and $3.24 in its latest
trading session and ended it at $3.19, up 1.92 percent. The stock's 52 weeks
range stands at $1.57 and $3.55. Astex Pharma. is up 62.76 percent in the past
12 months, while it gained 9 percent so far this year. The stock is in a
bullish mode and may find its first support level at $3.17. It is trading
below its 20-day moving average of $3.29 but above its 50-day average price of
$3.14. Sign up and read the complimentary report on ASTX at

Shares of Raptor Pharma ended their previous trading session marginally lower
at $4.98, down 0.40 percent. The stock lost more than 14 percent this year, in
contrast to the broad market. The stock has slipped from $5.03 resistance
level. It has support at around $4.87 at the moment. With its downward
movement, Raptor is trading below its 20-day moving average price. The stock
may touch $5.08 level in the coming trading sessions. The free report on RPTP
can be downloaded by signing up now at

About is a financial website where investors can have easy, precise
and comprehensive research and opinions on stocks making the headlines. Sign
up today to talk to our financial analyst at


Contact: William T. Knight, Email:, Contact Number:
+1-646-396-9857 (9:00 am EST - 01:30 pm EST)
Press spacebar to pause and continue. Press esc to stop.